MedTrace Logo

Autologous Stem Cells in Achilles Tendinopathy

NCT02064062 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-05-12

No results posted yet for this study

Summary

This study is looking at a new treatment, using the patient's own stem cells (the repair cells of the body), to see whether this can help reduce pain and promote healing of the Achilles tendon, without side effects.

Conditions

  • Achilles Tendinitis, Right Leg
  • Achilles Tendinitis
  • Achilles Degeneration
  • Achilles Tendon Thickening
  • Tendinopathy
  • Achilles Tendinitis, Left Leg

Interventions

BIOLOGICAL

Autologous Mesenchymal Stem Cells

Sponsors & Collaborators

  • University College, London

    lead OTHER

Principal Investigators

  • Andrew Goldberg, MBBS MD FRCSI FRCS(Tr&Orth) · Royal National Orthopaedic Hospital NHS Trust, UCL

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02064062 on ClinicalTrials.gov